[{"data": {"name": "Immunogenicity of MenB-FHbp (Bivalent rLP2086), a Meningococcal Serogroup B Vaccine, in US Adolescents: Results From a Phase 3 Trial", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Timo Vesikari", "@type": "Person"}, {"name": "Shelly Senders", "@type": "Person"}, {"name": "Judith Absalon", "@type": "Person"}, {"name": "Joseph J. Eiden", "@type": "Person"}, {"name": "Kathrin U. Jansen", "@type": "Person"}, {"name": "Johannes F. Beeslaar", "@type": "Person"}, {"name": "Laura J. York", "@type": "Person"}, {"name": "Thomas R. Jones", "@type": "Person"}, {"name": "Roger Maansson", "@type": "Person"}, {"name": "Shannon L. Harris", "@type": "Person"}, {"name": "Robert E. O'Neill", "@type": "Person"}, {"name": "John Ginis", "@type": "Person"}, {"name": "Annaliesa S. Anderson", "@type": "Person"}, {"name": "John L. Perez", "@type": "Person"}], "license": "cc-by-nc-nd", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://academic.oup.com/ofid/article-pdf/3/suppl_1/720/28687721/ofw172.583.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "Oxford University Press (OUP)", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1093/ofid/ofw172.583", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCYgYTkLcZYyS-CTrwRWCG7pvaR-CDYnmPFfdLibc-CRfbd4qg6Kzmk", "propertyID": "ISCC"}], "datePublished": "2016-01-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]